[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100492777":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":35,"responsibleParty":82,"collaborators":20,"id":84,"slug":20,"hasResults":85,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":20,"eligibilityCriteria":89,"healthyVolunteers":85,"sex":90,"minAge":91,"maxAge":20,"enrollmentInfo":92,"targetDuration":20,"studyType":95,"phases":96,"briefSummary":98,"conditions":99,"keywords":20,"overallStatus":38,"whyStopped":20,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":110},{"fullName":5,"class":6},"New World Medical, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment with a Canaloplasty Device","OTHER","US. FDA Approved Canaloplasty Device",[13],"Device: Canaloplasty Device",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Canaloplasty Device","Canaloplasty",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Mini Balaram, MD","STUDY_DIRECTOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},"Swetha Mandava, MS","CONTACT","9732049467","smandava@newworldmedical.com",{"name":32,"role":28,"phone":33,"phoneExt":20,"email":34},"Elysia Ison, OD,FAAO","4083487408","eison@newworldmedical.com",[36,51,68],{"facility":37,"status":38,"city":39,"state":20,"zip":20,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Centro de la Vision","RECRUITING","Santiago","Chile","CL",{"type":43,"coordinates":44},"Point",[45,46],-70.64827,-33.45694,{"lat":46,"lon":45},[49],{"name":50,"role":28,"phone":20,"phoneExt":20,"email":20},"Edison Villagran",{"facility":52,"status":38,"city":53,"state":20,"zip":20,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":60,"contacts":61},"Clínica 20\u002F20","San José","Costa Rica","CR",{"type":43,"coordinates":57},[58,59],-84.08489,9.93388,{"lat":59,"lon":58},[62,65],{"name":63,"role":28,"phone":64,"phoneExt":20,"email":20},"Nadja Dodero","+506 8375-8263",{"name":66,"role":67,"phone":20,"phoneExt":20,"email":20},"Claudio Orlich, MD","PRINCIPAL_INVESTIGATOR",{"facility":69,"status":70,"city":71,"state":20,"zip":20,"country":72,"countryCode":73,"cosmosGeoPoint":74,"geoPoint":78,"contacts":79},"Centro Oftalmologico Robles","NOT_YET_RECRUITING","Santa Rosa de Copán","Honduras","HN",{"type":43,"coordinates":75},[76,77],-88.7756,14.77388,{"lat":77,"lon":76},[80],{"name":81,"role":28,"phone":20,"phoneExt":20,"email":20},"Gricelda Ortiz",{"type":83,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100492777",false,"NCT05696561","Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma","A Prospective, Multicenter, First in Human Clinical Trial to Evaluate the Safety and Effectiveness of the DF12 CANALOPLASTY AND TRABECULOTOMY SURGICAL SYSTEM in Subjects With Open-Angle Glaucoma Undergoing Cataract Surgery","Inclusion Criteria:\n\n1. Subjects qualifying for cataract surgery\n2. Subjects with diagnosis of open-angle glaucoma in at least one eye with unmedicated IOP of 22-34 mmHg.\n\nExclusion Criteria:\n\n1\\. Patients who cannot be washed-out of IOP-lowering medications.","ALL","22 Years",{"count":93,"type":94},70,"ESTIMATED","INTERVENTIONAL",[97],"NA","Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects with Open-Angle Glaucoma",[100],"OAG - Open-Angle Glaucoma","2026-02-24",{"date":103,"type":104},"2026-02-27","ACTUAL",{"date":106,"type":104},"2025-09-09",{"date":108,"type":94},"2027-10",{"name":5,"class":6},3]